Genome Engineering via CRISPR-Cas9 System

Genome Engineering via CRISPR-Cas9 System

1st Edition - February 18, 2020

Write a review

  • Editors: Vijai Singh, Pawan Dhar
  • Paperback ISBN: 9780128181409
  • eBook ISBN: 9780128181416

Purchase options

Purchase options
Available
DRM-free (PDF, EPub, Mobi)
Sales tax will be calculated at check-out

Institutional Subscription

Free Global Shipping
No minimum order

Description

Genome Engineering via CRISPR-Cas9 Systems presents a compilation of chapters from eminent scientists from across the globe who have established expertise in working with CRISPR-Cas9 systems. Currently, targeted genome engineering is a key technology for basic science, biomedical and industrial applications due to the relative simplicity to which they can be designed, used and applied. However, it is not easy to find relevant information gathered in a single source. The book contains a wide range of applications of CRISPR in research of bacteria, virus, algae, plant and mammalian and also discusses the modeling of drosophila, zebra fish and protozoan, among others. Other topics covered include diagnosis, sensor and therapeutic applications, as well as ethical and regulatory issues. This book is a valuable source not only for beginners in genome engineering, but also researchers, clinicians, stakeholders, policy makers, and practitioners interested in the potential of CRISPR-Cas9 in several fields.

Key Features

  • Provides basic understanding and a clear picture on how to design, use and implement the CRISPR-Cas9 system in different organisms
  • Explains how to create an animal model for disease research and screening purposes using CRISPR
  • Discusses the application of CRISPR-Cas9 systems in basic sciences, biomedicine, virology, bacteriology, molecular biology, neurology, cancer, industry, and many more

Readership

Researchers in genome engineering, synthetic biology, metabolic engineering

Table of Contents

  • 1. An introduction to genome editing CRISPR-Cas systems
    2. Evolution and mechanism of CRISPR-Cas9 systems
    3. Exploring the potential of CRISPR-Cas9 for removal of human viruses
    4. Programmable removal of bacterial pathogens using CRISPR-Cas9 system
    5. Targeted genome editing using CRISPR-Cas9 system in fungi
    6. CRISPR-Cas9 system for fungi genome engineering towards industrial applications
    7. Development and challenges of using CRISPR-Cas9 system in mammalians
    8. CRISPR technology for cell line development and engineering
    9. Exploring the potential of genome editing CRISPR-Cas9 system in cancer
    10. CRISPR-Cas9 for therapy: the challenges and ways to overcome them
    11. Engineered Cas9 nucleases
    12. The current progress of CRISPR/Cas9 development in plants
    13. Fruit crops improvement using CRISPR-Cas9 system
    14. CRISPR-Cas9 engineered viral immunity in plants
    15. Genome engineering in medicinally important plants using CRISPR/Cas9 tool
    16. Genome editing of algal species by CRISPR Cas9 for biofuels
    17. Development and use of CRISPR in industrial applications
    18. CRISPR interference based gene silencing in bacteria: Advantages and limitations
    19. Genome engineering in insects: focus on the CRISPR/Cas9 system
    20. Recent Progress of CRISPR- Cas9 in Zebra Fish
    21. CRISPR: a revolutionary tool for genome engineering in the protozoan parasites
    22. Biosafety, biosecurity, patents, and regulatory issues

Product details

  • No. of pages: 384
  • Language: English
  • Copyright: © Academic Press 2020
  • Published: February 18, 2020
  • Imprint: Academic Press
  • Paperback ISBN: 9780128181409
  • eBook ISBN: 9780128181416

About the Editors

Vijai Singh

Dr. Vijai Singh is an Associate Professor and Dean (Research & Innovation) at School of Sciences, Indrashil University, Rajpur, Mehsana, Gujarat, India. He was an Assistant Professor in the Department of Biological Sciences and Biotechnology at the Institute of Advanced Research, Gandhinagar, India and also an Assistant Professor in the Department of Biotechnology at the Invertis University, Bareilly, India. Prior to that, he was a Postdoctoral Fellow in the Synthetic Biology Group at the Institute of Systems and Synthetic Biology, Paris, France and School of Energy & Chemical Engineering at the Ulsan National Institute of Science and Technology, Ulsan, South Korea. He received his Ph.D. in Biotechnology (2009) from the National Bureau of Fish Genetic Resources, Uttar Pradesh Technical University, Lucknow, India with a research focus on the development of molecular and immunoassays for diagnosis of Aeromonas hydrophila. His research interests are focused on building novel biosynthetic pathways for production of medically and industrially important biomolecules. Additionally, his laboratory is working on CRISPR-Cas9 tools for genome editing. He has more than 10 years of research and teaching experience in synthetic biology, metabolic engineering, bioinformatics, microbiology, and industrial microbiology. He has published 79 articles, 49 chapters, 12 books and 4 patents. He serves as an associate editor, editorial board member, and reviewer of several peer-reviewed journals. He is also a member of the Board of Study and Academic Council of Indrashil University and is the Member Secretary of the Institutional Biosafety Committee (IBSC) at the same University.

Affiliations and Expertise

Associate Professor and Dean, Department of Biosciences, School of Science, Indrashil University, Rajpur, Mehsana, Gujarat, India

Pawan Dhar

Prof. Pawan K. Dhar is the Dean, School of Biotechnology, Jawaharlal Nehru University, New Delhi and heads an active synthetic biology group. Prior to this he held scientific positions at RIKEN Institute, Keio University and Kyoto University (Japan) Bioinformatics Institute, (Singapore) and Manipal University (India). Prof. Dhar received his Ph.D. in 1993 from Banaras Hindu University (Varanasi) for his work on Human Genetics. Prof Dhar’s lab holds specialization in making functional proteins from non-expressing DNA sequences leading to the development of a potentially groundbreaking drug discovery platform. Prof. Dhar serves in the external board of referees for European Science Foundation and Indian Government science funding agencies.

Affiliations and Expertise

School of Biotechnology, Jawaharlal Nehru University, New Delhi, India

Ratings and Reviews

Write a review

There are currently no reviews for "Genome Engineering via CRISPR-Cas9 System"